Clinical Trials Directory

Trials / Completed

CompletedNCT06444516

Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease

A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects With Dry Eye Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
188 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate and demonstrate the efficacy and safety of an investigational ocular lubricant formulation in patients with mild to moderate dry eye disease (DED).

Detailed description

The study will consist of a Screening visit, a Baseline visit on Day 1, a remote Compliance Check on Day 14, and an Exit visit on Day 30. The expected study duration of participation for each subject is 37 days, with 30 ± 5 days of exposure to the investigational product.

Conditions

Interventions

TypeNameDescription
OTHERFID123300 ocular lubricantInvestigational ocular lubricant

Timeline

Start date
2024-09-04
Primary completion
2025-02-07
Completion
2025-02-07
First posted
2024-06-05
Last updated
2026-02-18
Results posted
2026-02-18

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06444516. Inclusion in this directory is not an endorsement.